Effects of APOE e4, age, and HIV on glial metabolites and cognitive deficits

Neurology

Volumn 82, Issue 24, 2014, Pages 2213-2222

  Chang, Linda ^a   Jiang, Caroline ^a   Cunningham, Eric ^a   Buchthal, Steven ^a   Douet, Vanessa ^a   Andres, Marilou ^b   Ernst, Thomas ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; CREATINE; INOSITOL; CHOLINE;

ADULT; ALLELE; ARTICLE; ATTENTION; BASAL GANGLION; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; EVALUATION STUDY; EXECUTIVE FUNCTION; FEMALE; FLUENCY MEMORY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MEMORY; METABOLITE; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE SCANNER; PARIETAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER; WORKING MEMORY; AGING; CROSS-SECTIONAL STUDY; FRONTAL LOBE; GENETICS; GLIA; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PATHOPHYSIOLOGY; VIROLOGY;

ADULT; AGING; APOLIPOPROTEIN E4; CHOLINE; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; FRONTAL LOBE; HIV SEROPOSITIVITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INOSITOL; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; NEUROGLIA; NEUROPSYCHOLOGICAL TESTS;

EID: 84903955752     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000526     Document Type: Article

References (38)

1. Heaton RK, Franklin DR, Ellis RJ, et al. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 2011;17: 3-16.
2. Harold D, Abraham R, Hollingworth P, et al. Genomewide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009; 41: 1088-1093.
3. Burt TD, Agan BK, Marconi VC, et al. Apolipoprotein (apo) E4 enhances HIV-1 cell entry in vitro, and the APOE epsilon4/epsilon4 genotype accelerates HIV disease progression. Proc Natl Acad Sci USA 2008;105: 8718-8723.
4. Valcour V, Shikuma C, Shiramizu B, et al. Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol 2004;157: 197-202.
5. Chang L, Andres M, Sadino J, et al. Impact of apolipoprotein E epsilon4 and HIV on cognition and brain atrophy: antagonistic pleiotropy and premature brain aging. Neuroimage 2011;58: 1017-1027.
6. Spector SA, Singh KK, Gupta S, et al. APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors. AIDS 2010; 24: 1471-1479.
7. Corder EH, Robertson K, Lannfelt L, et al. HIV-infected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nat Med 1998;4: 1182-1184.
8. Andres MA, Feger U, Nath A, Munsaka S, Jiang CS, Chang L. APOE epsilon 4 allele and CSF APOE on cognition in HIV-infected subjects. J Neuroimmune Pharmacol 2011; 6: 389-398.
9. Joska JA, Combrinck M, Valcour VG, et al. Association between apolipoprotein E4 genotype and human immunodeficiency virus-associated dementia in younger adults starting antiretroviral therapy in South Africa. J Neurovirol 2010;16: 377-383.
10. Morgan EE, Woods SP, Letendre SL, et al. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders. J Neurovirol 2013;19: 150-156.
11. Tuminello ER, Han SD. The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations. Int J Alzheimers Dis 2011;2011: 726197.
12. Morley D, McNamara P, Kennelly S, McMahon G, Bergin C. Limitations to the identification of HIVassociated neurocognitive disorders in clinical practice. HIV Med 2013;14: 497-502.
13. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007;69: 1789-1799.
14. Ernst T, Kreis R, Ross BD. Absolute quantitation of water and metabolites in the human brain: I: compartments and water. J Magn Reson B 1993;102: 1-8.
15. Chang L, Feger U, Ernst T. Brain imaging (CT, SPECT, PET, functional MRI & MRS) studies in HIV-associated brain disorders. In: Gendelman H, Grant I, Everall I, Lipton S, Swindells S, editors. The Neurology of AIDS, 3rd ed. Oxford, UK: Oxford University Press; 2012.
16. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE. Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 2005; 64: 529-536.
17. Ratai EM, Pilkenton S, He J, et al. CD81 lymphocyte depletion without SIV infection does not produce metabolic changes or pathological abnormalities in the rhesus macaque brain. J Med Primatol 2011;40: 300-309.
18. Cinque P, Vago L, Mengozzi M, et al. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 1998;12: 1327-1332.
19. Letendre SL, Zheng JC, Kaul M, et al. Chemokines in cerebrospinal fluid correlate with cerebral metabolite patterns in HIV-infected individuals. J Neurovirol 2011;17: 63-69.
20. Chang L, Ernst T, Poland R, Jenden D. In vivo proton magnetic resonance spectroscopy of the normal human aging brain. Life Sci 1996;58: 2049-2056.
21. Ernst T, Jiang C, Nakama H, Buchthal S, Chang L. Lower brain glutamate is associated with cognitive deficits in HIV patients: a new mechanism for HIV-associated neurocognitive disorder. J Magn Reson Imaging 2010;32: 1045-1053.
22. Chang L, Holt JL, Yakupov R, Jiang CS, Ernst T. Lower cognitive reserve in the aging human immunodeficiency virus-infected brain. Neurobiol Aging 2013;34: 1240-1253.
23. Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997;203: 829-836.
24. Egensperger R, Kosel S, von Eitzen U, Graeber MB. Microglial activation in Alzheimer disease: association with APOE genotype. Brain Pathol 1998;8: 439-447.
25. Zhu Y, Nwabuisi-Heath E, Dumanis SB, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia 2012;60: 559-569.
26. Chang L, Ernst T, Witt M, et al. Relationships among cerebral metabolites, cognitive function and viral loads in antiretroviral-naïve HIV patients. Neuroimage 2002;17: 1638-1648.
27. Laakso MP, Hiltunen Y, Kononen M, et al. Decreased brain creatine levels in elderly apolipoprotein E epsilon 4 carriers. J Neural Transm 2003;110: 267-275.
28. Bracco L, Piccini C, Baccini M, et al. Pattern and progression of cognitive decline in Alzheimer's disease: role of premorbid intelligence and ApoE genotype. Dement Geriatr Cogn Disord 2007;24: 483-491.
29. Teasdale GM, Nicoll JA, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997;350: 1069-1071.
30. Shi J, Zhao CB, Vollmer TL, Tyry TM, Kuniyoshi SM. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. Neurology 2008; 70: 185-190.
31. Jahanshad N, Valcour VG, Nir TM, et al. Disrupted brain networks in the aging HIV1 population. Brain Connect 2012;2: 335-344.
32. Barnes LL, Arvanitakis Z, Yu L, Kelly J, De Jager PL, Bennett DA. Apolipoprotein E and change in episodic memory in blacks and whites. Neuroepidemiology 2013; 40: 211-219.
33. Soontornniyomkij V, Moore DJ, Gouaux B, et al. Cerebral beta-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE epsilon4 carriers. AIDS 2012;26: 2327-2335.
34. Johnstone M, Gearing AJ, Miller KM. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol 1999;93: 182-193.
35. Schlesinger D, Grinberg LT, Alba JG, et al Brazilian Aging Brain Study Group. African ancestry protects against Alzheimer's disease-related neuropathology. Mol Psychiatry 2013;18: 79-85.
36. Tang MX, Stern Y, Marder K, et al. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA 1998;279: 751-755.
37. Chang L, Munsaka SM, Kraft-Terry S, Ernst T. Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain. J Neuroimmune Pharmacol 2013;8: 576-593.
38. Anthony IC, Norrby KE, Dingwall T, et al. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers. Brain 2010;133: 3685-3698.